3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
CNS
1
Conditions
Lymphoma
4
Sleep Initiation and Maintenance Disorders
2
Multiple Myeloma
2
Lymphoma, Follicular
2
Glioblastoma
2
Fatigue
2
Anxiety Disorders
2
Uterine Neoplasms
1
Sleep Wake Disorders
1
Pancreatic Neoplasms
1
Pain
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neoplasms
1
Meningioma
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Hodgkin Disease
1
Glioma
1
Generalized Anxiety Disorder
1
Esophageal Neoplasms
1
Depression
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Psychiatric Rehabilitation
2
Bortezomib
2
trametinib
1
sonidegib
1
ribociclib
1
entinostat
1
carboxyamido-triazole
1
Vorinostat
1
Thalidomide
1
Temozolomide
1
Paclitaxel
1
Granulocyte Colony-Stimulating Factor
1
Gemcitabine
1
Gelclair
1
Filgrastim
1
Fentanyl
1
Docetaxel
1
Cognitive Behavioral Therapy
1
90Y-octreotide, DOTA-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Meningioma
×
Cognitive Behavioral Therapy
×
Lymphoid
×
Clear all
NCT06439420
2025-10-01
CBT-I in PBT
Virginia Commonwealth University
Phase 2
Completed
70 enrolled